NCT06767566View on ClinicalTrials.gov

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 28, 2025

Primary Completion Date

December 7, 2027

Study Completion Date

March 31, 2028

Conditions
PainPostpartum Depression
Interventions
DRUG

Ketamine (Ketalar)

Loading Dose: 0.18 mg/kg/hr x 1 hour; Maintenance Dose 0.05 mg/kg/hr x 11 hours

Trial Locations (2)

15213

RECRUITING

Magee Womens Hospital of UPMC, Pittsburgh

RECRUITING

UPMC Montefiore Clinical and Translational Research Center, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Grace Lim, MD, MS

OTHER